A composition and its preparation method and application in preparing products with whitening effect
By combining Chinese medicinal materials such as Atractylodes, Baiwei, Bai and Tribulus in specific proportions and solvents, and combining the silica gel column elution conditions, the problem of insufficient inhibitory activity of tyrosinase in the prior art was solved, and significant results were achieved The inhibitory effect of tyrosinase provides important application value for whitening products.
Patent Information
- Application Number
- CN202310716345.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-16
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2043-06-16
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of natural drug chemistry, and in particular to a composition and a preparation method thereof and application thereof in preparing products with whitening effects. Background Art
[0002] Tyrosinase is an enzyme that regulates melanin production; tyrosine is converted into DOPA under the action of tyrosinase, and then melanin is finally produced through a series of steps. Melanin can make the skin of animals appear darker, especially black and brown. However, the expression and activity of tyrosinase determine the speed and output of melanin production. The higher the tyrosinase activity, the more melanin is formed in the skin. Therefore, the development of a composition that can inhibit the activity of tyrosinase has important application value for reducing the production of melanin and further whitening the skin.
[0003] Atractylodes macrocephala, Bletilla striata, Bletilla striata and Tribulus terrestris are common Chinese medicinal materials; however, the existing technology has little research on the effective ingredients that inhibit tyrosinase activity; therefore, using them as raw materials to develop effective ingredients that inhibit tyrosinase activity has important application prospects for developing products with whitening effects. Summary of the invention
[0004] In order to overcome at least one of the technical problems existing in the prior art, the present invention first provides a composition and a preparation method thereof.
[0005] The above technical problems to be solved by the present invention are achieved through the following technical solutions:
[0006] A preparation method of a composition, which is prepared by taking Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris as raw materials.
[0007] Preferably, the method for preparing the composition comprises the following steps:
[0008] (1) mixing Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris evenly to obtain a raw material mixture;
[0009] (2) extracting the raw material mixture with a solvent to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract, i.e., the composition.
[0010] The inventors found in their research that the composition prepared by the method of the present invention using the Chinese medicinal materials Atractylodes macrocephala, Bletilla striata, Bletilla striata and Tribulus terrestris as raw materials has certain tyrosinase inhibitory activity; therefore, the composition prepared by the method of the present invention is used as a tyrosinase inhibitor and further used in the development of skin care products or medicines with whitening effects, which has important application value.
[0011] More preferably, in step (1), the weight ratio of Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris is 1-3:1-3:1-3:1-3.
[0012] Most preferably, in step (1), the weight ratio of Atractylodes macrocephala, Bletilla striata, Bletilla striata and Tribulus terrestris is 1:1:1:1.
[0013] Further preferably, in step (2), the ratio of the raw material mixture to the solvent is 1 kg:10-15 L.
[0014] Most preferably, the ratio of the raw material mixture to the solvent in step (2) is 1 kg:12 L.
[0015] Preferably, the solvent is selected from water or ethanol.
[0016] Further preferably, the solvent consists of cyclohexane and n-butanol.
[0017] Preferably, the volume ratio of cyclohexane to n-butanol is 2 to 3:1.
[0018] The inventors found in their research that, in the process of preparing the composition of the present invention, the selection of the extract solvent plays an important role in the tyrosinase inhibitory activity of the prepared composition. The inventors surprisingly found in their research that the composition prepared using Atractylodes macrocephala, Rhizoma Cibotii, Rhizoma Bletillae and Rhizoma Tribuluse as raw materials and using a mixed solvent consisting of cyclohexane and n-butanol has a significantly higher tyrosinase inhibitory activity than the composition prepared using water or ethanol.
[0019] In addition, the inventors also found in the study that the tyrosinase inhibitory activity of the composition prepared by using a single cyclohexane or n-butanol composition, or the composition prepared by using other combinations of solvents, is not improved or significantly improved compared with the composition prepared by using ethanol; only the composition prepared by using a mixed solvent consisting of cyclohexane and n-butanol can have a tyrosinase inhibitory activity significantly higher than that of the composition prepared by using ethanol.
[0020] Further preferably, the preparation method of the composition further comprises the following steps: applying the Chinese medicine extract to a silica gel column, first eluting with a mixed solvent consisting of chloroform and methanol in a volume ratio of 77 to 75:23 to 25 to obtain eluent A, and discarding eluent A; then eluting with a mixed solvent consisting of chloroform and methanol in a volume ratio of 65 to 62:35 to 38 to obtain eluent B, concentrating and drying eluent B to obtain the effective part of the Chinese medicine, i.e., the composition.
[0021] Most preferably, the preparation method of the composition further comprises the following steps: applying the Chinese medicine extract to a silica gel column, first eluting with a mixed solvent consisting of chloroform and methanol in a volume ratio of 76:24 to obtain eluent A, and discarding eluent A; then eluting with a mixed solvent consisting of chloroform and methanol in a volume ratio of 63:37 to obtain eluent B, concentrating and drying eluent B to obtain the effective part of the Chinese medicine, i.e., the composition.
[0022] The inventors surprisingly found in further studies that the tyrosinase inhibitory activity of the composition prepared by the silica gel column elution conditions of the present invention was further significantly improved compared with that of the traditional Chinese medicine extract.
[0023] The inventors also found in the study that the silica gel column elution conditions are very critical, and they play a decisive role in whether the tyrosinase inhibitory activity of the prepared composition can be further significantly improved. If the silica gel column elution conditions are not selected properly, it cannot further enrich the effective ingredients with tyrosinase inhibitory activity, and thus cannot further improve or significantly improve the tyrosinase inhibitory activity of the composition. The inventors surprisingly found in a large number of experiments that only the composition prepared under the silica gel column elution conditions of the present invention can further significantly improve its tyrosinase inhibitory activity compared with the Chinese medicine extract; while the composition prepared under other silica gel column elution conditions cannot further improve or significantly improve its tyrosinase inhibitory activity compared with the Chinese medicine extract.
[0024] The present invention also provides a composition prepared by the above preparation method.
[0025] The present invention also provides a composition with whitening effect, which comprises the composition prepared by the above preparation method and a compound with whitening effect;
[0026] The compound with whitening effect is selected from one or a combination of α-lipoic acid, arbutin and nicotinamide.
[0027] In addition, the composition of the present invention can also be used in combination with other known compounds having whitening effects.
[0028] The present invention also provides an application of the above composition in preparing a tyrosinase inhibitor.
[0029] The present invention also provides an application of the composition in preparing a product with whitening effect.
[0030] Preferably, the product is a skin care product or a medicine.
[0031] Beneficial effects: The present invention provides a new composition; studies have shown that the composition prepared by the method of the present invention using the Chinese medicinal materials Atractylodes macrocephala, Bletilla striata, Bletilla striata and Tribulus terrestris as raw materials has a certain tyrosinase inhibitory activity; therefore, the composition prepared by the method of the present invention is used as a tyrosinase inhibitor and is further used to develop skin care products or medicines with whitening effects, which has important application value. DETAILED DESCRIPTION
[0032] The present invention is further explained below in conjunction with specific examples, but the examples do not limit the present invention in any form.
[0033] Example 1 Preparation of the composition
[0034] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 1:1:1:1 to obtain a raw material mixture;
[0035] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract, i.e., the composition;
[0036] The ratio of the raw material mixture to the solvent is 1kg:12L; the solvent is water.
[0037] Example 2 Preparation of the composition
[0038] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 1:1:1:1 to obtain a raw material mixture;
[0039] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract, i.e., the composition;
[0040] The ratio of the raw material mixture to the solvent is 1kg:12L; the solvent is an ethanol aqueous solution with a volume fraction of 70%.
[0041] Example 3 Preparation of the composition
[0042] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 1:1:1:1 to obtain a raw material mixture;
[0043] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract, i.e., the composition;
[0044] The ratio of the raw material mixture to the solvent is 1 kg:12 L; the solvent is composed of cyclohexane and n-butanol in a volume ratio of 2:1.
[0045] Example 4 Preparation of the composition
[0046] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 1:1:1:1 to obtain a raw material mixture;
[0047] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract; wherein the ratio of the raw material mixture to the solvent is 1 kg:12 L; and the solvent is composed of cyclohexane and n-butanol in a volume ratio of 2:1;
[0048] (3) The Chinese herbal medicine extract is loaded onto a silica gel column (the filler used in the silica gel column is 200-300 mesh silica gel; the weight of the silica gel is 30 times the weight of the Chinese herbal medicine extract), firstly eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 76:24 for 3 times the column volume to obtain eluent A, and then discarded the eluent A; then eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 63:37 for 5 times the column volume to obtain eluent B, and concentrated and dried the eluent B to obtain the effective part of the Chinese herbal medicine, i.e., the composition.
[0049] Example 5 Preparation of the composition
[0050] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 3:3:1:1 to obtain a raw material mixture;
[0051] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract; wherein the ratio of the raw material mixture to the solvent is 1 kg:10 L; and the solvent is composed of cyclohexane and n-butanol in a volume ratio of 3:1;
[0052] (3) The Chinese herbal medicine extract is loaded onto a silica gel column (the filler used in the silica gel column is 200-300 mesh silica gel; the weight of the silica gel is 30 times the weight of the Chinese herbal medicine extract), firstly eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 77:23 for 3 times the column volume to obtain eluent A, and then discarded the eluent A; then eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 65:35 for 5 times the column volume to obtain eluent B, and concentrated and dried the eluent B to obtain the effective part of the Chinese herbal medicine, i.e., the composition.
[0053] Example 6 Preparation of Composition
[0054] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Rhizoma Tribuluse in a weight ratio of 1:1:3:3 to obtain a raw material mixture;
[0055] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract; wherein the ratio of the raw material mixture to the solvent is 1 kg:15 L; and the solvent is composed of cyclohexane and n-butanol in a volume ratio of 2:1;
[0056] (3) The Chinese herbal medicine extract is loaded onto a silica gel column (the filler used in the silica gel column is 200-300 mesh silica gel; the weight of the silica gel is 30 times the weight of the Chinese herbal medicine extract), firstly eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 75:25 for 3 times the column volume to obtain eluent A, and then discarded the eluent A; then eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 62:38 for 5 times the column volume to obtain eluent B, and concentrated and dried the eluent B to obtain the effective part of the Chinese herbal medicine, i.e., the composition.
[0057] Comparative Example 1 Preparation of the composition
[0058] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 1:1:1:1 to obtain a raw material mixture;
[0059] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract, i.e., the composition;
[0060] The ratio of the raw material mixture to the solvent is 1 kg:12 L; the solvent is cyclohexane.
[0061] Comparative Example 2 Preparation of the composition
[0062] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 1:1:1:1 to obtain a raw material mixture;
[0063] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract, i.e., the composition;
[0064] The ratio of the raw material mixture to the solvent is 1kg:12L; the solvent is n-butanol.
[0065] Comparative Example 3 Preparation of Composition
[0066] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 1:1:1:1 to obtain a raw material mixture;
[0067] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract, i.e., the composition;
[0068] The ratio of the raw material mixture to the solvent is 1 kg:12 L; the solvent is composed of water and n-butanol in a volume ratio of 2:1.
[0069] Comparative Example 4 Preparation of Composition
[0070] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 1:1:1:1 to obtain a raw material mixture;
[0071] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract, i.e., the composition;
[0072] The dosage ratio of the raw material mixture to the solvent is 1kg:12L; the solvent is composed of 70% ethanol aqueous solution and n-butanol in a volume ratio of 2:1.
[0073] Comparative Example 5 Preparation of Composition
[0074] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 3:3:1:1 to obtain a raw material mixture;
[0075] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract; wherein the ratio of the raw material mixture to the solvent is 1 kg:10 L; and the solvent is composed of cyclohexane and n-butanol in a volume ratio of 3:1;
[0076] (3) The Chinese herbal medicine extract is loaded onto a silica gel column (the filler used in the silica gel column is 200-300 mesh silica gel; the weight of the silica gel is 30 times the weight of the Chinese herbal medicine extract), firstly eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 95:5 for 3 times the column volume to obtain eluent A, and then discarded the eluent A; then eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 80:20 for 5 times the column volume to obtain eluent B, and concentrated and dried the eluent B to obtain the effective part of the Chinese herbal medicine, i.e., the composition.
[0077] Comparative Example 6 Preparation of Composition
[0078] (1) mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Radix Bletillae and Tribulus terrestris in a weight ratio of 3:3:1:1 to obtain a raw material mixture;
[0079] (2) mixing the raw material mixture with a solvent, and then heating to 75° C. for reflux extraction for 2 hours to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract; wherein the ratio of the raw material mixture to the solvent is 1 kg:10 L; and the solvent is composed of cyclohexane and n-butanol in a volume ratio of 3:1;
[0080] (3) The Chinese herbal medicine extract is loaded onto a silica gel column (the filler used in the silica gel column is 200-300 mesh silica gel; the weight of the silica gel is 30 times the weight of the Chinese herbal medicine extract), firstly eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 65:35 for 3 times the column volume to obtain eluent A, and then discarded the eluent A; then eluted with a mixed solvent consisting of chloroform and methanol in a volume ratio of 50:50 for 5 times the column volume to obtain eluent B, and concentrated and dried the eluent B to obtain the effective part of the Chinese herbal medicine, i.e., the composition.
[0081] Experimental Example 1 Tyrosinase Inhibition Activity Test
[0082] Test method: 50 μL of L-DOPA solution, test sample solution and / or tyrosinase solution were added to a 96-well plate, mixed evenly and reacted in a water bath (30°C) for 30 minutes; then the absorbance A (490 nm) was tested; each group of tests was repeated 3 times, and the average value of the 3 tests was taken; and the tyrosinase inhibition rate was calculated; the test results are shown in Table 1.
[0083] The above-mentioned L-DOPA solution, the test sample solution and the tyrosinase solution are prepared with 0.2 mol / L phosphate buffer solution with a pH of 6.8; wherein the concentrations of the L-DOPA solution and the test sample solution are 1 mg / mL; the concentration of the tyrosinase solution is 100 U / mL; the test sample is the composition prepared in Examples 1 to 6 and Comparative Examples 1 to 6.
[0084] Tyrosinase inhibition rate = [1-(A T1 -A T2 ) / (A C1 -A C2 )]x100%;
[0085] Among them, A T1 A is the absorbance under the conditions of adding tyrosinase solution and adding the sample solution to be tested; T2 A is the absorbance without tyrosinase solution and with the sample solution to be tested; C1 A is the absorbance under the condition of adding tyrosinase solution but not adding the drug sample solution to be tested; C2 It is the absorbance without adding tyrosinase solution and sample solution to be tested.
[0086] Table 1. Tyrosinase inhibitory activity test results
[0087] Tyrosinase inhibition rate The composition prepared in Example 1 43.5% Example 2 Composition prepared 51.6% Example 3 Composition prepared 76.8% Example 4 Composition prepared 97.9% Example 5 Composition prepared 90.4% Example 6 Composition prepared 92.2% The composition prepared in Comparative Example 1 60.2% The composition prepared in Comparative Example 2 54.1% The composition prepared in Comparative Example 3 50.5% The composition prepared in Comparative Example 4 53.6% The composition prepared in Comparative Example 5 70.1% The composition prepared in Comparative Example 6 79.2%
[0088] It can be seen from the experimental data in Table 1 that the compositions prepared in Examples 1 to 6 have certain tyrosinase inhibitory activity, and the differences in tyrosinase inhibitory activity between the compositions prepared by different methods are huge.
[0089] It can also be seen from the experimental data in Table 1 that the composition prepared in Example 3 has a significantly higher tyrosinase inhibitory activity than the compositions prepared in Examples 1 and 2; this indicates that the composition prepared using Atractylodes macrocephala, Fragrant osmanthus fragrans, Bletilla striata and Tribulus terrestris as raw materials and using a mixed solvent consisting of cyclohexane and n-butanol has a significantly higher tyrosinase inhibitory activity than the composition prepared using water or ethanol.
[0090] It can also be seen from the experimental data in Table 1 that the tyrosinase inhibitory activity of the compositions prepared in Comparative Examples 1 to 4 is not significantly improved compared with the composition prepared in Example 2; the improvement is much smaller than that of the composition prepared in Example 3; this shows that the tyrosinase inhibitory activity of the compositions prepared by using a single cyclohexane or n-butanol composition, or the compositions prepared by using other combinations of solvents, cannot be significantly improved compared with the compositions prepared by using ethanol; only the compositions prepared by using a mixed solvent composed of cyclohexane and n-butanol can have a tyrosinase inhibitory activity significantly higher than that of the compositions prepared by using ethanol.
[0091] It can also be seen from the experimental data in Table 1 that the composition prepared in Example 4 has a tyrosinase inhibitory activity that is significantly higher than that of the composition prepared in Example 3; it has very excellent tyrosinase inhibitory activity; this shows that the composition prepared by the silica gel column elution conditions of the present invention has a tyrosinase inhibitory activity that is further significantly improved compared to the traditional Chinese medicine extract.
[0092] It can also be seen from the experimental data in Table 1 that the tyrosinase inhibitory activity of the compositions prepared in Comparative Examples 5 and 6 is not further improved or significantly improved compared with the composition prepared in Example 3; this shows that the silica gel column elution conditions of the present invention are very critical, and play a decisive role in whether the tyrosinase inhibitory activity of the prepared composition can be further significantly improved; the above experimental results show that only the composition prepared under the silica gel column elution conditions of the present invention can have a further significantly improved tyrosinase inhibitory activity compared with the Chinese medicine extract; and the compositions prepared under other silica gel column elution conditions cannot have a further improved or significantly improved tyrosinase inhibitory activity compared with the Chinese medicine extract.
Claims
1. A method for preparing a composition having a whitening effect, It is characterized in that With Chinese herbal medicine Atractylodes macrocephala, It is prepared with Bletilla striata, Bletilla striata and Tribulus terrestris as raw materials; The method for preparing the composition is characterized in that it specifically comprises the following steps: (1) Evenly mixing the Chinese medicinal materials Atractylodes macrocephala, Radix Bupleuri, Bletilla striata and Tribulus terrestris in a weight ratio of 1:1:1:1 to obtain a raw material mixture; (2) extracting the raw material mixture with a solvent to obtain an extract; concentrating and drying the extract to obtain a Chinese medicine extract, i.e., the composition having whitening effect; The solvent consists of cyclohexane and n-butanol in a volume ratio of 2-3:
1.
2. The method for preparing the composition having whitening effect according to claim 1, It is characterized in that In step (2), the ratio of the raw material mixture to the solvent is 1 kg:10-15 L.
3. The method for preparing the composition having whitening effect according to claim 1, It is characterized in that The ratio of the raw material mixture to the solvent in step (2) is 1 kg:12 L.
4. A composition with whitening effect prepared by the preparation method according to any one of claims 1 to 3.
5. A composition having a whitening effect, It is characterized in that A composition prepared by the preparation method according to any one of claims 1 to 3 and a compound having a whitening effect; The compound with whitening effect is selected from one or a combination of α-lipoic acid, arbutin and nicotinamide.
6. Use of the composition with whitening effect according to claim 4 or 5 in the preparation of tyrosinase inhibitors.
7. Use of the composition with whitening effect according to claim 4 or 5 in the preparation of products with whitening effect.
